Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Hahn, David L ^a   Schure, Allison ^b   Patel, Katir ^b   Childs, Tawanna ^b   Drizik, Eduard ^b   Webley, Wilmore ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DNA; IMMUNOGLOBULIN E; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BLOOD; CASE CONTROL STUDY; CHILD; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEVERE PERSISTENT ASTHMA; CHLAMYDOPHILA INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ASTHMA; AZITHROMYCIN; CASE-CONTROL STUDIES; CHILD; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84860152177     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035945     Document Type: Article

References (62)

1. Chobot R, Uvitsky IH, Dundy H, (1951) The relationship of the etiologic factors in asthma in infants and children. J Allergy 22: 106-110.
2. Gern JE, Busse WW, (2000) The role of viral infections in the natural history of asthma. J Allergy Clin Immunol 106: 201-212.
3. Welliver RC, Kaul TN, Ogra PL, (1980) The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. New Engl J Med 303: 1198-1202.
4. Hahn DL, (1999) Chlamydia pneumoniae, asthma and COPD: what is the evidence? Ann Allergy Asthma Immunol 83: 271-292.
5. Hansbro PM, Beagley KW, Horvat JC, Gibson PG, (2004) Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacology and Therapeutics 101: 193-210.
6. Johnston SL, Martin RJ, (2005) Chlamydophila pneumoniae and Mycoplasma pneumoniae. A role in asthma pathogenesis? Am J Respir Crit Care Med 172: 1078-1089.
7. von Hertzen L, Vasankari T, Liippo K, Wahlström E, Puolakkainen M, (2002) Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis 34: 22-27.
8. Hahn DL, (2004) Role of Chlamydia pneumoniae as an inducer of asthma. In: Friedman H, Yamamoto Y, Bendinelli M, editors. Chlamydia pneumoniae Infection and Disease New York Kluwer Academic/Plenum Publishers pp. 239-262.
9. Allegra L, Blasi F, Centanni S, Cosentini R, Denti F, et al. (1994) Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J 7: 2165-2168.
10. Hahn DL, Peeling RW, (2008) Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60. Ann Allergy Asthma Immunol 101: 614-618.
11. Emre U, Sokolovskaya N, Roblin P, Schacter J, Hammerschlag M, (1995) Detection of Chlamydia pneumoniae-IgE in children with reactive airway disease. J Infect Dis 172: 265-267.
12. Hahn DL, Peeling RW, Dillon E, McDonald R, Saikku P, (2000) Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol 84: 227-233.
13. Ikezawa S, (2001) Prevalence of Chlamydia pneumoniae in acute respiratory tract infection and detection of anti-Chlamydia pneumoniae-specific IgE in Japanese children with reactive airway disease. Kurume Med J 48: 165-170.
14. Seggev JS, Kurup VP, (1992) Mycoplasma pneumoniae (MP) infection induces production of specific IgE and IgG4. J Allergy Clin Immunol 89 Abstracts 230.
15. Yano T, Tanaka Y, Takeda K, Koga H, Ichikawa Y, et al. (1992) Detection of Mycoplasma-specific IgE in patients with Mycoplasma pneumonia and its clinical significance. Am Rev Respir Dis 145: A497.
16. Global Initiative for Asthma (GINA) 2007 (2007) Global Strategy for Asthma Management and Prevention. Available from: http://wwwginasthmaorg.
17. Kadooka Y, Idota T, Gunji H, Shimatani M, Kawakami H, et al. (2000) A method for measuring specific IgE in sera by direct ELISA without interference by IgG competition or IgG autoantibodies to IgE. Int Arch Allergy Immunol 122: 264-269.
18. Souza-Atta ML, Araujo MI, D'Oliveira Junior A, Ribeiro-de-Jesus A, Almeida RP, et al. (1999) Detection of specific IgE antibodies in parasite diseases. Braz J Med Biol Res 32: 1101-1105.
19. Birmingham N, Payankaulam S, Thanesvorakul S, Stefura B, HayGlass K, et al. (2003) An ELISA-based method for measurement of food-specific IgE antibody in mouse serum: an alternative to the passive cutaneous anaphylaxis assay. J Immunol Methods 275: 89-98.
20. Montigiani S, Falugi F, Scarselli M, Finco O, Petracca R, et al. (2002) Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 70: 368-379.
21. Tanzer RJ, Hatch TP, (2001) Characterization of outer membrane proteins in Chlamydia trachomatis LGV serovar L2. J Bacteriol 183: 2686-2690.
22. Webley WC, Tilahun Y, Lay K, Patel K, Stuart ES, et al. (2009) Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in pediatric respiratory infections. Eur Respir J 33: 360-367.
23. Gaydos CA, Eiden JJ, Bobo LD, Quinn TC, (1992) Identification of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunosorbant assay. Abstracts of the American Society of Microbiology D-132: 118.
24. DeGraves FJ, Gao D, Kaltenboeck B, (2003) High-sensitivity quantitative PCR platform. Biotechniques 34: 106-110 112-105.
25. Herland K, Akselsen J-P, Skjønsberg OH, Bjermer L, (2005) How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 99: 11-19.
26. Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, et al. (2007) External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 62: 219-223.
27. Expert Panel Report 3 (2007) Guidelines for the diagnosis and management of asthma. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute.
28. Gibson PG, Simpson JL, (2009) The overlap syndrome of asthma and COPD: what are its features and how important is it? BMJ 64: 728-735.
29. Burrows B, Martinez F, Halonen M, Barbee RA, Cline MG, (1989) Association of asthma with serum IgE levels and skin-test reactivity to allergens. New Engl J Med 320: 271-277.
30. Welliver RC, Wong DT, Middleton E, Sun M, McCarthy N, et al. (1982) Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatrics 101: 889-896.
31. Hahn DL, Azenabor AA, Beatty WL, Byrne GI, (2002) Chlamydia pneumoniae as a respiratory pathogen. Frontiers Biosci 7: E66-76.
32. Saikku P, (1993) Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. European Heart Journal 14 (Supplement K): 62-65.
33. Blasi F, Arioso C, Cavallaro G, Betti M, Dotti C, et al. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of bronchial infection. In: Saikku P, editors. 2000; Helsinki, Finland. Esculapio, Bologna Italy.
34. Ciocca DR, Adams DJ, Bjercke RJ, Sledge GW Jr, Edwards DP, et al. (1983) Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. J Histochem Cytochem 31: 691-696.
35. Henderson CE, Ownby D, Klebanoff M, Levine RJ, (1998) Stability of immunoglobulin E (IgE) in stored obstetric sera. J Immunol Methods 213: 99-101.
36. Hamilton RG, (2010) Clinical laboratory assessment of immediate-type hypersensitivity. J Allergy Clin Immunol 125: S284-296.
37. da Costa CP, Kirschning CJ, Busch D, Dürr S, Jenen L, et al. (2002) Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Eur J Immunol 32: 2460-2470.
38. Hahn DL, Peeling RW, (2008) Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60. Ann Allergy Asthma Immunol 101: 614-618.
39. Stone KD, Prussin C, Metcalfe DD, (2010) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125: S73-80.
40. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH, (2001) A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107: 595-601.
41. Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, et al. (2008) Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol 180: 2225-2232.
42. Blasi F, Aliberti S, Allegra L, Piatti G, Tarsia P, et al. (2007) Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice. Respir Res 8: 83.
43. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NC, et al. (2008) Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176: 556-564.
44. Schröder NWJ, Crother TM, Naiki Y, Chen S, Wong MH, et al. (2008) Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. J Allergy Clin Immunol 122: 595-602.
45. Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, et al. (2010) Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 125: 617-625.
46. Morinaga Y, Yanagihara K, Miyashita N, Seki M, Izumikawa K, et al. (2009) Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. Pulmonary Pharmacology & Therapeutics doi:10.1016/j.pupt.2009.08.004.
47. Asquith KL, Horvat JC, Kaiko GE, Carey AJ, Beagley KW, et al. (2011) Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog 7: e1001339.
48. Hollams EM, Hales BJ, Bachert C, Huvenne W, Parsons F, et al. (2010) Th2-associated immunity to bacteria in teenagers and susceptibility to asthma. Eur Respir J 36: 509-516.
49. Chen C-Z, Yang B-C, Lin T-M, Lee C-H, (2009) Chronic and repeated Chlamydophila pneumoniae lung infection can result in increasing IL-4 gene expression and thickness of airway subepithelial basement membrane in mice. J Formos Med Assoc 108: 45-52.
50. Beigelman A, Gunsten S, Mikols CL, Vidavsky I, Cannon CL, et al. (2009) Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma. Chest 136: 498-506.
51. Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, et al. (2010) Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J Immunol doi:10,4049/jimmunol.0902287.
52. Hahn DL, (1995) Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J Fam Pract 41: 345-351.
53. Hahn DL, Plane MB, Mahdi OS, Byrne GI, (2006) Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma. PLoS Clin Trials 1: e11 DOI:10.1371/journal.pctr0010011.
54. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG, (2008) Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177: 148-155.
55. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG, (2011) Immunomodulatory effects of macrolide antibiotics- part 1: biological mechanisms. Respiration 81: 67-74.
56. Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, et al. (2011) Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 140: 401-407.
57. Burián K, Hegyesi H, Buzás E, Endrész V, Kis Z, et al. (2003) Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Immunology Letters 89: 229-236.
58. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M, (1998) Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell & Mol Biol 19: 721-727.
59. Rizzo A, Di Domenico M, Carratelli CR, Mazzola N, Paolillo R, (2011) Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae. Cytokine 56: 450-457.
60. Wolf K, Plano GV, Fields KA, (2009) A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1. Cellular Microbiology 11: 769-779.
61. Shemer-Avni Y, Lieberman D, (1995) Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis 171: 1274-1278.
62. Jahn H-U, Krüll M, Wuppermann FN, Klucken AC, Rosseau S, et al. (2000) Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J Infect Dis 182: 1678-1687.